{
    "2019-04-15": [
        [
            {
                "time": "",
                "original_text": "中信建投医药|行业周报：积极关注医疗信息化、国企改革投资主线",
                "features": {
                    "keywords": [
                        "医疗信息化",
                        "国企改革",
                        "投资主线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "建议关注医药国改机会，港股医药配置价值凸显｜【光大医药·周报】",
                "features": {
                    "keywords": [
                        "医药国改",
                        "港股医药",
                        "配置价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "工业大麻“幕后玩家”",
                "features": {
                    "keywords": [
                        "工业大麻",
                        "幕后玩家"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "工业大麻"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "太极集团：巨额营销打头阵背后 研发脱节 营运乏力",
                "features": {
                    "keywords": [
                        "太极集团",
                        "营销",
                        "研发脱节",
                        "营运乏力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【有声】津同仁堂—核心中药品种增长稳健，2018年净利润达1.43亿元【安信诸海滨团队】",
                "features": {
                    "keywords": [
                        "津同仁堂",
                        "核心中药品种",
                        "增长稳健",
                        "净利润"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}